Tag Archives: Ahead

Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst

Confronting generic pricing pressure that put a hard cap on profits, Pfizer’s Upjohn spinoff deal with Mylan allowed both companies to reinvent themselves in the face of stagnant growth. The Pfizer left over after the merger could be a “messy” one, one analyst says, but brighter days should be on the horizon. After shedding its generics business,… Read More »

Celgene executives whipped up new, lucrative severance plans ahead of Bristol-Myers megadeal

It’s not only Celgene investors who are set for a big payoff with this week’s $ 74 billion sale to Bristol-Myers Squibb. Thanks to brand-new severance agreements inked days ahead of the deal announcement, its top executives could reap hefty gains, too. Under change-in-control severance arrangements that took effect Dec. 17, top Celgene managers would… Read More »

AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus approval, phase 3 data

The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »